These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 11089976)

  • 1. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.
    Kleemann R; Hausser A; Geiger G; Mischke R; Burger-Kentischer A; Flieger O; Johannes FJ; Roger T; Calandra T; Kapurniotu A; Grell M; Finkelmeier D; Brunner H; Bernhagen J
    Nature; 2000 Nov; 408(6809):211-6. PubMed ID: 11089976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
    Hwang CY; Ryu YS; Chung MS; Kim KD; Park SS; Chae SK; Chae HZ; Kwon KS
    Oncogene; 2004 Nov; 23(55):8868-75. PubMed ID: 15480426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell.
    Li Y; Lu C; Xing G; Zhu Y; He F
    Exp Cell Res; 2004 Nov; 300(2):379-87. PubMed ID: 15475002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1.
    Tomoda K; Kubota Y; Kato J
    Nature; 1999 Mar; 398(6723):160-5. PubMed ID: 10086358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
    Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
    Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
    Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
    Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adapter protein NRBP associates with Jab1 and negatively regulates AP-1 activity.
    Wang H; Sun X; Luo Y; Lin Z; Wu J
    FEBS Lett; 2006 Oct; 580(25):6015-21. PubMed ID: 17052710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracrine hepatopoietin potentiates AP-1 activity through JAB1 independent of MAPK pathway.
    Lu C; Li Y; Zhao Y; Xing G; Tang F; Wang Q; Sun Y; Wei H; Yang X; Wu C; Chen J; Guan KL; Zhang C; Chen H; He F
    FASEB J; 2002 Jan; 16(1):90-2. PubMed ID: 11709497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors.
    Claret FX; Hibi M; Dhut S; Toda T; Karin M
    Nature; 1996 Oct; 383(6599):453-7. PubMed ID: 8837781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1.
    Tanaka Y; Kanai F; Ichimura T; Tateishi K; Asaoka Y; Guleng B; Jazag A; Ohta M; Imamura J; Ikenoue T; Ijichi H; Kawabe T; Isobe T; Omata M
    Oncogene; 2006 Jan; 25(4):633-42. PubMed ID: 16247477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif.
    Burger-Kentischer A; Finkelmeier D; Thiele M; Schmucker J; Geiger G; Tovar GE; Bernhagen J
    FEBS Lett; 2005 Mar; 579(7):1693-701. PubMed ID: 15757663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Watanabe Y; Yamaguchi F; Hatano N; Tokuda M
    Clin Cancer Res; 2005 Jan; 11(1):259-66. PubMed ID: 15671554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of human thioltransferase (hTTase) gene by AP-1 transcription factor under oxidative stress.
    Krysan K; Lou MF
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1876-83. PubMed ID: 12036993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta.
    Onodera S; Nishihira J; Koyama Y; Majima T; Aoki Y; Ichiyama H; Ishibashi T; Minami A
    Arthritis Rheum; 2004 May; 50(5):1437-47. PubMed ID: 15146413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
    Kouvaraki MA; Rassidakis GZ; Tian L; Kumar R; Kittas C; Claret FX
    Cancer Res; 2003 Jun; 63(11):2977-81. PubMed ID: 12782606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer.
    Fukumoto A; Ikeda N; Sho M; Tomoda K; Kanehiro H; Hisanaga M; Tsurui Y; Tsutsumi M; Kato JY; Nakajima Y
    Oncol Rep; 2004 Feb; 11(2):277-84. PubMed ID: 14719054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic investigation on the development of molecular targeting therapy against cyclin-dependent kinase inhibitor p27Kip1 in head and neck cancer cells.
    Supriatno ; Harada K; Yoshida H; Sato M
    Int J Oncol; 2005 Sep; 27(3):627-35. PubMed ID: 16077910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The constitutive photomorphogenesis 9 signalosome directs vascular endothelial growth factor production in tumor cells.
    Pollmann C; Huang X; Mall J; Bech-Otschir D; Naumann M; Dubiel W
    Cancer Res; 2001 Dec; 61(23):8416-21. PubMed ID: 11731421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
    Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
    J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.